Status:
COMPLETED
The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Hyperglycemia in Critically Ill Patients
Eligibility:
All Genders
18-75 years
Brief Summary
Abstract: Hyperglycemia, hypoglycemia, and glucose variability in ICU patients are associated with adverse outcomes. Continuous Glucose Monitoring Systems (CGMS) offer dynamic glucose monitoring and e...
Eligibility Criteria
Inclusion
- Inclusion criteria included
- Age ≥18 years and ≤75 years;
- Expected ICU stay of at least 3 days;
- Elevated blood glucose (BG \>180 mg/dL) requiring intravenous insulin therapy;
- Informed consent obtained from the patient or their legally authorized representative.
- Exclusion criteria included
- Severe hepatic failure (Child-Pugh class C) or marked liver dysfunction (total bilirubin ≥50 μmol/L and alanine aminotransferase ≥3 times the upper limit of normal);
- Uncorrected diabetic ketoacidosis; ability to self-feed; planned magnetic resonance imaging (MRI) examination;
- Pregnancy or breastfeeding;
- Extensive skin burns, dermatitis, or severe infections precluding the use of a continuous glucose monitoring system;
- Severe brain injury, brain death, or moribund state;
- Deemed unsuitable for study participation by the investigator.
Exclusion
Key Trial Info
Start Date :
May 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 10 2024
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT07201155
Start Date
May 1 2024
End Date
October 10 2024
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China, 510000